Vomiting: all 1,123 studies

Page 3 of 12. Open to participants first (137), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Triple Therapy With Palonosetron for PON ProphylaxisCompletedNCT02635828Phase 4Results posted
• Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNCT02625181Not applicableResults posted
• Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus AprepitantCompletedNCT02597907Not applicableResults posted
• Low Doses of Ketamine and Postoperative Quality of RecoveryCompletedNCT02571153Phase 4Results posted
• An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and VomitingCompletedNCT02557035Phase 3Results posted
• Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast CancerCompletedNCT02550795Not applicableResults posted
• Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)TerminatedNCT02519842Phase 3Results posted
• A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and VomitingCompletedNCT02517021Phase 3Results posted
• Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and VomitingCompletedNCT02484911Phase 3Results posted
• Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)CompletedNCT02473042Not applicableResults posted
• Granisetron Transdermal Patch for Prevention of Postoperative Nausea and VomitingCompletedNCT02457195Phase 2Results posted
• Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) TrialCompletedNCT02456662Not applicableResults posted
• Study of APD421 as PONV Treatment (no Prior Prophylaxis)CompletedNCT02449291Phase 3Results posted
• Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using IV-PCACompletedNCT02448862Results posted
• Clinical Use of Baxter Animated Retching Faces (BARF) Scale in ChildrenCompletedNCT02421952Results posted
• Effect of Steroids on Post-tonsillectomy MorbiditiesCompletedNCT02401529Phase 2Results posted
• Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic GastroparesisCompletedNCT02357420Phase 2Results posted
• BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or GastritisCompletedNCT02246439Phase 3Results posted
• Satisfactory Analgesia Minimal Emesis in Day SurgeriesCompletedNCT02223377Not applicableResults posted
• Acupuncture for Chemotherapy-Induced Nausea and VomitingCompletedNCT02195921Not applicableResults posted
• Effect of Intraoperative Crystalloid Volume on Postoperative VomitingCompletedNCT02177201Not applicableResults posted
• Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) ReconstructionTerminatedNCT02161705Phase 3Results posted
• Efficacy Side-effect Score (ESS): Development and Evaluation of a New Tool for Patients After SurgeryCompletedNCT02143128Not applicableResults posted
• Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility StudyCompletedNCT02129478Phase 2Results posted
• Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic ChemotherapyCompletedNCT02116530Phase 3Results posted
• A Comparison of Targinact vs. Oxycodone on Gut Function After Colorectal SurgeryCompletedNCT02109640Phase 3Results posted
• A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HECCompletedNCT02106494Phase 3Results posted
• Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving ChemotherapyCompletedNCT02097823Phase 2Results posted
• Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and VomitingCompletedNCT02096835Not applicableResults posted
• Inhalation Intervention for Nausea in the Emergency DepartmentCompletedNCT02092441Not applicableResults posted
• Use of Baxter Animated Retching Faces (BARF) Scale to Measure Nausea in Children Who Speak SpanishCompletedNCT02007109Results posted
• Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and VomitingCompletedNCT02006056Phase 2Results posted
• Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic?CompletedNCT01912807Not applicableResults posted
• Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell CarcinomaTerminatedNCT01874119Phase 2Results posted
• Dose-finding Study of APD403 to Prevent Nausea and Vomiting After ChemotherapyCompletedNCT01857232Phase 2Results posted
• Dexamethasone for Post-cesarean Delivery PainCompletedNCT01812057Phase 4Results posted
• IV Acetaminophen for Postoperative AnalgesiaTerminatedNCT01798316Phase 4Results posted
• Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell TumorsCompletedNCT01736917Phase 2Results posted
• Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean SectionsCompletedNCT01734161Phase 4Results posted
• Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section PatientsCompletedNCT01733212Phase 2/3Results posted
• A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)CompletedNCT01732458Phase 2Results posted
• Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to GastroparesisCompletedNCT01711918Not applicableResults posted
• Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)CompletedNCT01700140Phase 2Results posted
• Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)CompletedNCT01697579Phase 2Results posted
• A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)CompletedNCT01636947Phase 4Results posted
• Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CASActive, not recruitingNCT01626079Not applicableResults posted
• A Comparison of Tumescence in Breast Reduction SurgeryCompletedNCT01602692Phase 4Results posted
• Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)CompletedNCT01594749Phase 3Results posted
• Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective SurgeryCompletedNCT01592708Not applicableResults posted
• Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With NauseaCompletedNCT01556932Not applicableResults posted
• Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic CancerCompletedNCT01534637Phase 2Results posted
• Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion SurgeryCompletedNCT01531439Not applicableResults posted
• Phase II Dose-ranging Study of APD421 in PONVCompletedNCT01510704Phase 2Results posted
• Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut SurgeryCompletedNCT01510379Not applicableResults posted
• Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination ChemotherapyCompletedNCT01504711Not applicableResults posted
• Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic ChemotherapyCompletedNCT01500226Phase 3Results posted
• Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic ChemotherapyCompletedNCT01500213Phase 3Results posted
• Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic ChemotherapyCompletedNCT01499849Phase 3Results posted
• Fosaprepitant in Patients Receiving Ifosfamide-based RegimenCompletedNCT01490060Not applicableResults posted
• Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and VomitingCompletedNCT01474915Phase 4Results posted
• Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving TemozolomideCompletedNCT01450826Phase 2Results posted
• Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric SurgeryCompletedNCT01449708Phase 4Results posted
• Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric PatientsCompletedNCT01442376Phase 3Results posted
• Management of Nausea and Vomiting Chemotherapy-induced in NormandyCompletedNCT01440465Results posted
• Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and VomitingCompletedNCT01432015Phase 4Results posted
• Acupuncture and Nausea/Vomiting in Pediatric PatientsCompletedNCT01417741Not applicableResults posted
• Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)TerminatedNCT01405924Phase 2Results posted
• Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric PatientsCompletedNCT01395901Phase 3Results posted
• A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and VomitingCompletedNCT01376297Phase 3Results posted
• Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant PatientsCompletedNCT01370408Phase 2Results posted
• An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and VomitingCompletedNCT01363479Phase 3Results posted
• A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)CompletedNCT01362530Phase 3Results posted
• Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyCompletedNCT01346267Not applicableResults posted
• An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and VomitingCompletedNCT01339260Phase 3Results posted
• Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.CompletedNCT01298193Phase 4Results posted
• Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian CancerTerminatedNCT01275664Not applicableResults posted
• Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating TabletsCompletedNCT01217190Phase 1/2Results posted
• Prevention of Intraoperative Nausea and Vomiting During Cesarean SectionCompletedNCT01216410Not applicableResults posted
• Carbidopa for the Treatment of Nausea and Vomiting in Familial DysautonomiaCompletedNCT01212484Phase 3Results posted
• Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid SurgeryCompletedNCT01189292Phase 3Results posted
• Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot StudyTerminatedNCT01183481Phase 2Results posted
• Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin TrialCompletedNCT01149369Phase 2Results posted
• Study of Impact of Not Measuring Residual Gastric Volume on Nosocomial Pneumonia RatesCompletedNCT01137487Not applicableResults posted
• Effect of Lidocaine and Esmolol to Improve the Quality of RecoveryTerminatedNCT01114997Phase 4Results posted
• Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)CompletedNCT01111851Phase 1Results posted
• Re-examination Study of EMEND (Aprepitant) (MK-0869-184)CompletedNCT01074255Results posted
• A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)CompletedNCT01054456Phase 2Results posted
• Gabapentin in the Prevention of Nausea and Vomiting Induced by ChemotherapyCompletedNCT01052844Phase 3Results posted
• Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By ChemotherapyTerminatedNCT01031953Phase 1/2Results posted
• Palonosetron Versus Ondansetron for the Prevention of Nausea and VomitingCompletedNCT01031498Phase 2Results posted
• Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/CarboplatinCompletedNCT01012336Phase 2Results posted
• A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)CompletedNCT00990821Phase 1Results posted
• Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill PatientsTerminatedNCT00982995Phase 2Results posted
• Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)CompletedNCT00972595Phase 1Results posted
• A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED)CompletedNCT00971633Phase 1Results posted
• Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)CompletedNCT00967499Phase 2Results posted
• Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)CompletedNCT00952341Phase 3Results posted
• A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)CompletedNCT00945321Phase 1Results posted
• The Effect of Electroacustimulation on Postoperative Nausea, Vomiting and Pain in Outpatient Plastic Surgery PatientsCompletedNCT00941005Not applicableResults posted
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted

← Vomiting overview